Adrenaline (Epinephrine) and Guanethidine (Ismelin), apart from supplementing the effect of Pilocarpine, are used in the treatment of open-angle glaucoma both alone and in combination, one with the other. The mechanisms of their individual and combined activity in reducing intraocular pressure (IOP), however, are still not fully understood.
effective in reducing intraocular pressure than would either drug alone. This has been indicated by the work ofRoth (I 973), Turner (i 968) , and Paterson and Paterson (1972) on unpublished results of Crombie.
Guanethidine and Adrenaline are marketed as individual solutions and are generally used in this way. In order to prevent the washing away of the active drug a time lapse is often advocated between instillation of the two formulations. One of us (DEPJ), using an interval of 30 min, has shown over a 2-year period that IOP in glaucomatous patients can be adequately controlled by this dosage regimen. If the postulated Guanethidine sensitization is rapidly achieved then it would be advantageous to patients if both drugs were to be combined in one formulation and so instilled at the same time.
Rabbits demonstrate a measurable decrease in IOP as a result of instillation into the eye of Adrenaline or Guanethidine. Rabbits were therefore used in this study which was aimed at elucidating the relationship between effectiveness and dosage protocol of Guanethidine and Adrenaline. All solutions were prepared with freshly boiled and cooled distilled water. They were sterilized by filtration through a 0-22 p membrane filter.
The experimental animals were six male New Zealand white rabbits aged between 4 and 8 months. They were conditioned to having eye drops instilled into their eyes and having their IOP measured daily for one month before the experiment began.
Intraocular pressure measurements were obtained with a Perkins hand-held applanation tonometer using benoxinate as a local anaesthetic before the measurements were taken. The rabbits were placed in a holding box whilst IOP measurements were made.
For the assessment of activity of the different dosage protocols on each day the rabbits were divided into three groups of two. Both members of each group were given one drop of the test formulation/s in one eye and a drop of sterile saline in the other. IOP measurements were then performed on both eyes at regular intervals until the IOP in the test eye had returned to the same value as the control eye. On each occasion the same groupings were used twice, on the first day the left eye being used as the test and on the second day the right eye. The rabbits were allowed 3 clear days between each experiment so that in each week three dosage protocols were tested, each on two rabbits. The normal crossover procedure was applied so that in the second and third week the rabbits were subjected to the two other dosage protocols. Thus by the end of 3 weeks all six rabbits had received drugs in each eye according to three different dosage protocols. This scheme is outlined in Table I . Results and discussion Variation in IOP of rabbits' eyes If the IOP of rabbits' eyes remained unchanged throughout a normal experimental period, or alternatively if the IOP changed in a systematic and reproducible manner, then the effect of drugs could be measured in both eyes, as a change in the expected IOP. To test this IOP measurements were made at intervals throughout the day on both eyes of all six rabbits. Measurements ofthis kind were carried out on four successive days, and the results for one rabbit are given in Fig. I . In order to test the efficiency of drugs in reducing IOP it was necessary to instill the drugs in one eye, using the other as the untreated control. For this to be justified it is necessary for the IOP of both untreated eyes of each rabbit to be similar. To test this, IOP measurements of all six rabbits were taken at intervals throughout each of four separate days. Fig. 2 shows the readings for the six rabbits on the same day.
As can be seen except in a few isolated cases the Fig. 3 and the mean IOP readings for the six rabbits together with their associated standard errors are given in Table II , for 2 and 5 hours after instillation of the drops. From Fig. 3 it appears that Guanethidine and Adrenaline given together produce a more intense effect which lasts longer than any of the other treatments. The next most efficient treatment is provided by Guanethidine followed 30 min later by Adrenaline. Although the difference in initial intensity compared with the remaining three treatments is negligible, the duration of effectiveness is longer, the effect being well maintained at 36 hours. In contrast Adrenaline alone, while initially having a reasonable effect, has lost its action by 36 hours. All IOP measurements were back to normal after 48 hours.
Visually the results appear to be unequivocal with the peak of activity being obtained after about 5 hours. Checking experiments were performed on single rabbits when readings were taken after 7 and 9 hours which indicated that the IOP readings were beginning to rise again. The greatest difference at the 5 hour level occurs between Adrenaline plus Guanethidine and Guanethidine alone. A Student's 't' test was carried out on these figures which gave a calculated value of 0-92 compared with the tabulated value of I -73 at the 5 per cent probability level. At the 2 hour level the same test was carried out for Adrenaline plus Guanethidine and Adrenaline alone and gave a value of I 14, the tabulated value again being 1-73. Thus the readings obtained for Adrenaline plus Guanethidine cannot statistically be taken as being different from the others. This result is due to the high standard errors of all the values, which were about 30 to 50 per cent of their corresponding mean values in all cases. This is because we cannot measure the IOPs with a precision greater than o0-mm which is approximately 20 to 40 per cent of the experimental readings. In view of these constraints it is probably not justified to use normal statistical tests, and the most that can be concluded is that Guanethidine given with Adrenaline tends to give results at least as good as those obtained when the drugs are given separately. Although Guanethidine followed by Adrenaline after 30 min is a standard treatment for glaucoma, the results with rabbits suggest that there is no advantage in administering the two types of drops separately. In view of the benefit to the patient obtained by giving both drugs in the same formulation it would appear sensible to attempt to treat patients with this combination.
Work undertaken in our laboratory has shown that there are no serious formulation problems associated with preparing a solution containing both drugs. The stability of the dual dosage is governed by the stability of the Adrenaline, and it is possible to prepare eye drops buffered to a pH of 7-0 to 7-2 with a shelf life at 40C of greater than one year, so that it will subsequently remain stable during normal domiciliary use.
The formulation can be adequately preserved by the addition of o-oi per cent w/v benzalkonium chloride and is best sterilized by filtration through a 0-22 y membrane.
The work, so far performed with rabbits, is encouraging. It is now necessary to subject eye drops containing I per cent Adrenaline and 5 per cent Guanethidine to extended trials on patients with chronic open-angle glaucoma.
Summary
The effect of Adrenaline o-s per cent and Guanethidine 2-5 per cent alone and in combination in reducing intraocular pressure in rabbits has been studied. Six rabbits were used and the efficiencies of 5 different dosage protocols was estimated both as intensity and duration of activity. The 5 dosage protocols were Adrenaline alone; Guanethidine alone; Adrenaline and Guanethidine together; Adrenaline followed in 30 min by Guanethidine; and Guanethidine followed in 30 min by Adrenaline. The single formulation containing both drugs appeared to be at least as efficient as the others. Eye drops containing I per cent Adrenaline and 5 per cent Guanethidine having sufficient stability for normal use have therefore been formulated. 
